Canadian approval of semaglutide copy could lower GLP1 costs for plan sponsors Canada could see one of the first generic versions of Ozempic on the market as early as this year, potentially reshaping access to GLP1 drugs
Mild water retention and peripheral edema, particularly during weeks one to four Transient flushing, warmth, or dizziness immediately post-injection Injection site reactions: redness, minor swelling Dose-dependent effects (above saturation dose of approximately 1 mcg/kg): Elevated cortisol via ACTH stimulation
Baseline electrocardiography may be considered in patients with known arrhythmias or significant cardiac history
Be sure to use a new needle for each injection and dispose of used needles in a sharps container
Massachusetts 48% Data shows that Massachusetts GLP-1 users increased by nearly 50% (48%, to be exact) in 2024
The benefits continue to build with regular treatments, providing sustained improvements in detoxification, immune support, and overall wellness